To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
NAMSA locks down buyer in ArchiMed
Concluding an Edgemont Partners sale process, the European suitor emerges with a deal that leaves management with an approximately 20% stake in the medical device services company.
